Want to see GB:49GP full AI Analyst Report?
49GP Stock Chart & Stats
87.00 p
0.00 p(0.00%)
At close: 4:00 PM EDT
87.00 p
0.00 p(0.00%)
Day’s Range― - ―
52-Week Range84.00 p - 93.00 p
Previous CloseN/A
Volume0.00
Average Volume (3M)173.00
Market Cap
£4.47B
Enterprise Value4.85B
Total Cash (Recent Filing)£205.30M
Total Debt (Recent Filing)£783.20M
Price to Earnings (P/E)56.7
Beta0.03
Next Earnings
Feb 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield758.62%
Share Statistics
EPS (TTM)0.57
Shares Outstanding499,000
10 Day Avg. Volume516
30 Day Avg. Volume173
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)1.72
Price to Sales (P/S)2.21
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Innovation-led Consumer Care Growth (Beauty Actives)Sustained double-digit growth in Beauty Actives and rapid adoption of new actives show durable product differentiation and successful 'design-in' with customers. Innovation-led segments typically command higher margins and sticky customer relationships, supporting lasting revenue and margin resilience versus commodity lines.
Margin Expansion From Transformation SavingsProgress on a structured transformation programme is delivering measurable cost savings and modest margin uplift. With a clear GBP100m target and GBP46m achieved, these operational efficiencies provide a durable lever to offset input cost pressure and support sustainable margin improvement over multiple years.
Solid Cash Generation And Recovering Free Cash FlowConsistent operating cash flow and a strong FCF rebound indicate robust cash generation ability intrinsic to specialty chemicals. Reliable cash flows fund capex, dividends and transformation while giving flexibility to manage debt, making the company's financial position more resilient over the medium term.
Bears Say
Muted Revenue Growth TrendFlat organic growth over successive years suggests limited top-line momentum outside pockets of outperformance. Without a broader acceleration, scale benefits and long-term EPS growth will rely heavily on margin actions and acquisitions, increasing execution risk if market end-demand softens.
Earnings Volatility And Sharp Net Income DeclineA steep fall in net income despite stable EBIT indicates below-the-line volatility (one-offs, financing or tax) that undermines earnings quality. Persistent volatility complicates forecasting, dividend sustainability and strategic reinvestment decisions, raising medium-term financial planning risk.
Elevated Working Capital And Project LumpinessHigher inventory and receivables and project-driven phasing (notably in Pharma Solutions) create structural cash conversion variability and funding needs. If project timing or demand lags, working-capital drag can persist, pressuring liquidity and reducing the pace at which transformation frees up cash.
49GP FAQ
What was Croda International PLC’s price range in the past 12 months?
Croda International PLC lowest share price was 84.00 p and its highest was 93.00 p in the past 12 months.
What is Croda International PLC’s market cap?
Croda International PLC’s market cap is £4.47B.
When is Croda International PLC’s upcoming earnings report date?
Croda International PLC’s upcoming earnings report date is Feb 23, 2027 which is in 203 days.
How were Croda International PLC’s earnings last quarter?
Currently, no data Available
Is Croda International PLC overvalued?
According to Wall Street analysts Croda International PLC’s price is currently Overvalued.
Does Croda International PLC pay dividends?
Croda International PLC pays a Semiannually dividend of 3.3 p which represents an annual dividend yield of 758.62%. See more information on Croda International PLC dividends here
What is Croda International PLC’s EPS estimate?
Croda International PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Croda International PLC have?
Croda International PLC has 499,000 shares outstanding.
What happened to Croda International PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Croda International PLC?
Currently, no hedge funds are holding shares in GB:49GP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Croda International Stock Smart Score
Company Description
Croda International PLC
Croda International Plc, founded in 1925 and based in Goole, UK, is a global enterprise dedicated to the innovation, production, and distribution of specialty chemicals. Its extensive reach covers Europe, the Middle East, Africa, North America, Asia, and Latin America, with operations segmented into Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers a vast portfolio of products serving diverse industries. This includes specialized ingredients for personal care items like skin, hair, sun, and oral hygiene, as well as cosmetics, deodorants, and men's grooming. In the agricultural sector, Croda supplies additives for crop protection, seed enhancement, and animal health, alongside bio-stimulants. For automotive and industrial applications, its offerings range from lubricant additives, coatings, and polymers to vehicle cleaning chemicals and specialty additives for plastics, batteries, and catalysts. Additionally, Croda provides solutions for construction chemicals, dietary supplements, active pharmaceutical ingredients, and advanced materials for electronics and devices. Other key product areas encompass food additives, specialty polymer additives for furniture, household and industrial cleaning products, oleochemicals, paints and coatings, and materials for packaging, print, and paper industries. A significant focus is on its bio-based phase change materials, engineered for thermal management in applications such as buildings, healthcare, electronics, food refrigeration, temperature-controlled packaging, and vehicles.



